
    
      This is an investigator initiated, randomized, double blind, placebo controlled, cross over
      study which is supported by Merz pharmaceuticals. Patients with Parkinson"s disease (at Yale
      Neurology and Movement disorders clinics) will be approached by the members of the research
      team (PI and sub-investigators) to see if they meet inclusion and exclusion criteria and wish
      to participate in the study.

      If eligible and consented to participate in the study, there will be a series of
      questionaires, examinations and treatment sessions.
    
  